Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4895]

Tumour gene test results can differ in same patients

Tumour gene test results can differ in same patients

Common breast cancer mutation could be vulnerable to drug combination

Common breast cancer mutation could be vulnerable to drug combination

Almost 20 percent of breast cancer patients fail to complete prescribed endocrine therapy

Almost 20 percent of breast cancer patients fail to complete prescribed endocrine therapy

SABCS 2016: Interim phase Ib/II results of pembrolizumab with eribulin for triple negative breast cancer

SABCS 2016: Interim phase Ib/II results of pembrolizumab with eribulin for triple negative breast cancer

Atezolizumab gives NSCLC patients extra four months of life with fewer side effects compared to chemotherapy

Atezolizumab gives NSCLC patients extra four months of life with fewer side effects compared to chemotherapy

'Rewired' cells show promise for targeted cancer therapy

'Rewired' cells show promise for targeted cancer therapy

SABCS 2016: Image-guided biopsy identifies patients who achieve pathologic complete response after neoadjuvant therapy

SABCS 2016: Image-guided biopsy identifies patients who achieve pathologic complete response after neoadjuvant...

SABCS 2016: Aromatase inhibitors associated with reduced endothelial function in postmenopausal breast cancer patients

SABCS 2016: Aromatase inhibitors associated with reduced endothelial function in postmenopausal breast cancer...

Guidelines for cancer care: slipping the net

Guidelines for cancer care: slipping the net

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

More from ecancer